Charles Marchese, DPM
Podiatrist · Manalapan, NJNPI 1417061854
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Kerecis Limited at 44.9% of the total. Reporting peaked in 2023 at $5,374 and has fallen 89.4% since, to $572 in 2025. Among podiatrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $131.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$6K
- Musculoskeletal Transplant Foundation Inc.$4K
- Advanced Oxygen Therapy Inc.$2K
- Stryker$1K
- Smith+Nephew$589
- Biotissue Holdings Inc.$271
- plus $551 from 15 others
What the payments were for
- Consulting fees$4,90035%
- Speaking & faculty fees$5,42239%
- Travel & lodging$7986%
- Food & beverage$2,80020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 9 | $6,253 |
| Musculoskeletal Transplant Foundation Inc. | 19 | $3,509 |
| Advanced Oxygen Therapy Inc. | 5 | $1,688 |
| Stryker(2 entities) | 10 | $1,058 |
| Smith+Nephew | 33 | $589 |
| Biotissue Holdings Inc. | 3 | $271 |
| Organogenesis Inc. | 6 | $103 |
| Next Science LLC | 3 | $76 |
| Bsn Medical Inc | 1 | $56 |
| Urgo Medical North America, LLC | 3 | $54 |
| Tactile Systems Technology Inc | 2 | $34 |
| Acera Surgical, Inc. | 2 | $33 |
| Cashflow Solutions, LLC | 2 | $30 |
| Hydrofera LLC | 1 | $29 |
| AbbVie | 1 | $27 |
| Bioventus LLC | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $22 |
| Convatec Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
| Biowound Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$12,748
- Kerecis Omega3 Marigen$12,198
- Kerecis Omega3 GraftGuide$6,086
- Topical oxygen chamber for extremities$1,625
- CROSSCHECK$462
- ORTHOLOC$205
- VARIAX$167
- PICO 14$137
How this compares
$13,920 in reported general payments places this provider in the 95th percentile of 382 podiatrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Allopurinol | 30 | $207 |
| Meloxicam | 102 | $199 |
| Methylprednisolone | 24 | $182 |
| Levofloxacin | 34 | $150 |
| Clindamycin Hcl | 20 | $83 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $76 |
| Ciprofloxacin Hcl | 17 | $74 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Manalapan
- Justin FlemingSomerset$1.2M
- Eric BaskinManahawkin$298K
- Jonathan RichardsEnglewood$79K
- Jack BondiSewell$53K
- Matthew WohlgemuthHammonton$49K
- Ritchard RosenEnglewood$44K
- Michael HuchitalLyndhurst$41K
- Jeffrey GewirtzPark Ridge$24K
- James SullivanSea Girt$19K
- Georgios KotziasParamus$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.